Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 10-Q 10/15/2014

I'm not sure the interpretation of preferred stock being issued now is correct. Some one needs to go back and look at a previous 10-Q and see if that same language is there?

Lots of information in this filing though.

IMO

Share
New Message
Please login to post a reply